Artículos científicos Open Access
Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain
Communications Biology
Airah Javorsky, Patrick O. Humbert & Marc Kvansakul
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Nature Communications
Nanda Kishore Routhu, Narayanaiah Cheedarla & Rama Rao Amara
Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States
Nature Communications
Bingyi Yang, Angkana T. Huang & Derek A. T. Cummings
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa
Nature Communications
Ben Morton, Kayla G. Barnes & Kondwani C. Jambo
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records
Nature Communications
Isobel Routledge, Adrienne Epstein & Isabel Rodriguez-Barraquer
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Nature
Jianying Liu, Yang Liu & Pei-Yong Shi
Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells
Scientific Reports
Jorgelina M. Calandria, et al
High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
Scientific Reports
Markus H. Kainulainen, et al
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Nature
Galit Alter, et al
Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1
Nature Communications
Jin Chai, et al
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland
Nature Communications
Silvia Stringhini, et al
Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave
Nature Communications
Matthew M. Hernandez, et al
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination
Nature Communications
Laura Matrajt, et al
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
Nature Communications
Alberto A. Amarilla, et al
